Clinical Trials Directory

Trials / Completed

CompletedNCT00946530

Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
118 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
55 Years – 100 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to demonstrate the efficacy of timed exposure to bright light for the treatment of disturbed nighttime sleep and daytime wake in community-dwelling dementia patients and their caregivers, and to determine if there are genetic relationships between memory problems and sleep problems

Detailed description

1. Efficacy: Up to 4 weeks of morning bright light exposure will be more efficacious than morning dim light in consolidating nighttime sleep as assessed by actigraphy. 2. Predictors of response: We expect the primary predictor of treatment response will be initial MMSE score. Secondary predictors include baseline sleep/wake and circadian parameters and age. 3. Effectiveness: Bright light treatment will be more effective than dim light in improving quality of life. 4. An understanding of some of the genetic markers of memory and/or sleep problems.

Conditions

Interventions

TypeNameDescription
DEVICEBright lightParticipants uses bright light
DEVICEControlParticipants uses dim light

Timeline

Start date
2004-09-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-07-27
Last updated
2018-10-03
Results posted
2017-03-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00946530. Inclusion in this directory is not an endorsement.